These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10932343)

  • 21. The effect of oral corticosteroids on bronchodilator responses in COPD.
    Corden Z; Rees PJ
    Respir Med; 1998 Feb; 92(2):279-82. PubMed ID: 9616526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to inhaled bronchodilators in COPD.
    Anthonisen NR; Wright EC
    Chest; 1987 May; 91(5 Suppl):36S-39S. PubMed ID: 2882959
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological treatment of exertional dyspnoea in stable COPD patients.
    Melani AS
    Monaldi Arch Chest Dis; 1997 Aug; 52(4):354-62. PubMed ID: 9401366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of acute bronchodilator responses in stable COPD to predict the relative efficacy of individual agents.
    Peacock MD; Johnson JE
    Chest; 1992 Jun; 101(6):1552-7. PubMed ID: 1600772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ipratropium bromide on pulmonary hemodynamics in COPD.
    Zieliński J
    Chest; 1995 Oct; 108(4):1181-2. PubMed ID: 7555146
    [No Abstract]   [Full Text] [Related]  

  • 26. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.
    Rennard SI; Serby CW; Ghafouri M; Johnson PA; Friedman M
    Chest; 1996 Jul; 110(1):62-70. PubMed ID: 8681667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for novel COPD therapies.
    Barnes PJ
    Pulm Pharmacol Ther; 1999; 12(2):67-71. PubMed ID: 10373383
    [No Abstract]   [Full Text] [Related]  

  • 28. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M
    Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Categorisation of ventilatory pattern of response to bronchodilator therapy in airflow limitation.
    Meenakshi S
    J Assoc Physicians India; 1995 Mar; 43(3):179-81. PubMed ID: 11256903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glucocorticoids treatment of exacerbation of chronic obstructive lung diseases].
    Dalsgarth OJ; Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):529-32. PubMed ID: 10697460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction in COPD experiment (ICE): a hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease.
    van Dijk WD; Heijdra Y; Scheepers PT; Lenders JW; van Weel C; Schermer TR
    Med Hypotheses; 2010 Feb; 74(2):277-80. PubMed ID: 19800175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preventive therapy essential in the treatment of patients with COPD].
    Postma DS; Quanjer PH
    Ned Tijdschr Geneeskd; 1992 Mar; 136(10):455-60. PubMed ID: 1347646
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical role of long-acting beta2-agonists in COPD.
    Kips J
    Respir Med; 2000 Sep; 94 Suppl E():S1-5. PubMed ID: 11001071
    [No Abstract]   [Full Text] [Related]  

  • 34. Propofol induces bronchodilation in mechanically ventilated chronic obstructive pulmonary disease (COPD) patients.
    Conti G; Dell'Utri D; Vilardi V; De Blasi RA; Pelaia P; Antonelli M; Bufi M; Rosa G; Gasparetto A
    Acta Anaesthesiol Scand; 1993 Jan; 37(1):105-9. PubMed ID: 8424280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease.
    Taube C; Lehnigk B; Paasch K; Kirsten DK; Jörres RA; Magnussen H
    Am J Respir Crit Care Med; 2000 Jul; 162(1):216-20. PubMed ID: 10903244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controversies in pulmonary medicine. Patients with COPD should be started initially on anticholinergic bronchodilators.
    Chapman KR; Wanner A
    Am Rev Respir Dis; 1988 Oct; 138(4):1074-5. PubMed ID: 2904777
    [No Abstract]   [Full Text] [Related]  

  • 38. Can 'old' lungs be restored? Strategies for preserving lung health and preventing and treating COPD.
    Petty TL
    Postgrad Med; 1998 Oct; 104(4):173-8, 181-2. PubMed ID: 9793563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of reversibility in patients with chronic airflow obstruction.
    Barros MJ; Rees PJ
    Br J Clin Pract; 1992; 46(2):132-5. PubMed ID: 1457301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COPD. Assessing functional status.
    Daly WJ
    Hosp Pract (Off Ed); 1985 Mar; 20(3A):73-7, 82-5, 89-93. PubMed ID: 3932414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.